Nishimura M - Search Results

1

Clinical Characteristics and Outcomes of Patients With Heart Failure and Methamphetamine Abuse.

Thomas IC, Nishimura M, Ma J, Dickson SD, Alshawabkeh L, Adler E, Maisel A, Criqui MH, Greenberg B. Thomas IC, et al. Among authors: nishimura m. J Card Fail. 2020 Mar;26(3):202-209. doi: 10.1016/j.cardfail.2019.10.002. Epub 2019 Oct 13. J Card Fail. 2020. PMID: 31618697

2

Characteristics and Outcomes of Methamphetamine Abuse Among Veterans With Heart Failure.

Nishimura M, Ma J, Fox S, Toomu A, Mojaver S, Juang DK, Maisel AS, Thomas IC. Nishimura M, et al. Am J Cardiol. 2019 Sep 15;124(6):907-911. doi: 10.1016/j.amjcard.2019.05.068. Epub 2019 Jun 26. Am J Cardiol. 2019. PMID: 31311659

3

The Impact of Substance Abuse on Heart Failure Hospitalizations.

Nishimura M, Bhatia H, Ma J, Dickson SD, Alshawabkeh L, Adler E, Maisel A, Criqui MH, Greenberg B, Thomas IC. Nishimura M, et al. Am J Med. 2020 Feb;133(2):207-213.e1. doi: 10.1016/j.amjmed.2019.07.017. Epub 2019 Jul 29. Am J Med. 2020. PMID: 31369724 Free PMC article.

4

Clinical and echocardiographic outcomes in heart failure associated with methamphetamine use and cessation.

Bhatia HS, Nishimura M, Dickson S, Adler E, Greenberg B, Thomas IC. Bhatia HS, et al. Among authors: nishimura m. Heart. 2021 May;107(9):741-747. doi: 10.1136/heartjnl-2020-317635. Epub 2020 Oct 5. Heart. 2021. PMID: 33020227 Free PMC article.

5

Methamphetamine-Associated Heart Failure Hospitalizations Across the United States: Geographic and Social Disparities.

Dickson SD, Thomas IC, Bhatia HS, Nishimura M, Mahmud E, Tu XM, Lin T, Adler E, Greenberg B, Alshawabkeh L. Dickson SD, et al. Among authors: nishimura m. J Am Heart Assoc. 2021 Aug 17;10(16):e018370. doi: 10.1161/JAHA.120.018370. Epub 2021 Aug 7. J Am Heart Assoc. 2021. PMID: 34365802 Free PMC article.

6

Systolic dysfunction in patients with methamphetamine use and heart failure with preserved ejection fraction.

Bhatia HS, Nishimura M, Martinez A, Vanam S, Kahn AM, DeMaria A, Thomas IC. Bhatia HS, et al. Among authors: nishimura m. Int J Cardiol. 2022 Feb 1;348:90-94. doi: 10.1016/j.ijcard.2021.12.024. Epub 2021 Dec 15. Int J Cardiol. 2022. PMID: 34921901 Free PMC article.

7

Benefits of Contemporary Implantable Cardioverter Defibrillators in Patients With Improved Ejection Fraction: When Is the Most Clinically Relevant Time to Evaluate?

Nishimura M, Thomas I, Hsu JC. Nishimura M, et al. JAMA Cardiol. 2017 Dec 1;2(12):1397. doi: 10.1001/jamacardio.2017.3448. JAMA Cardiol. 2017. PMID: 28973138 No abstract available.

8

An update on the use and discovery of prognostic biomarkers in acute decompensated heart failure.

Darden D, Nishimura M, Sharim J, Maisel A. Darden D, et al. Among authors: nishimura m. Expert Rev Mol Diagn. 2019 Nov;19(11):1019-1029. doi: 10.1080/14737159.2019.1671188. Epub 2019 Sep 27. Expert Rev Mol Diagn. 2019. PMID: 31539485 Review.

9

The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac Biomarkers.

Nishimura M, Brann A, Chang KW, Maisel AS. Nishimura M, et al. Curr Heart Fail Rep. 2018 Aug;15(4):239-249. doi: 10.1007/s11897-018-0398-4. Curr Heart Fail Rep. 2018. PMID: 29987498 Review.

10

Biomarkers: a window into the pathophysiology of atrial fibrillation in heart failure with reduced vs. preserved ejection fraction.

Nishimura M, Maisel AS. Nishimura M, et al. Eur Heart J. 2018 Nov 14;39(43):3876-3878. doi: 10.1093/eurheartj/ehy733. Eur Heart J. 2018. PMID: 30428036 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,509 results

Search Page

Filters